Bioneer A/S

Executive Summary

Bioneer A/S is a Danish life science company established in 1996, specializing in in vitro modelling, drug formulation, and recombinant protein manufacturing. The company provides innovative services and develops technologies at the intersection of genetics, genomics, synthetic biology, and diagnostics. By transforming scientific advancements into practical solutions for biotech and pharmaceutical companies, Bioneer supports drug development and biological research. With a strong foundation in contract research and manufacturing, the company is well-positioned to capitalize on the growing demand for outsourced R&D and biologics production in the Nordic region and beyond.

Upcoming Catalysts (preview)

• Q4 2026Partnership with a Top-20 Pharma for Drug Formulation Services60% success
• Q2 2027Launch of Expanded Recombinant Protein Manufacturing Capacity70% success
• Q3 2026Strategic Collaboration in Synthetic Biology for Diagnostics55% success